ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells.

Suyama, Hisashi

ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells. [electronic resource] - International journal of oncology Jun 2004 - 1499-504 p. digital

Publication Type: Comparative Study; Journal Article

1019-6439


Adenocarcinoma--drug therapy
Antineoplastic Agents, Phytogenic--pharmacology
Drug Resistance, Neoplasm
Enzyme Activation--drug effects
Enzyme Inhibitors--pharmacology
Extracellular Signal-Regulated MAP Kinases--metabolism
G1 Phase--drug effects
Gene Expression Regulation, Neoplastic
Humans
Lung Neoplasms--drug therapy
Paclitaxel--pharmacology
Phosphorylation--drug effects
Retinoblastoma Protein--drug effects
Tumor Cells, Cultured